Integra LifeSciences plans to spin-off its spine business and create a standalone public company.
The Latest
The North American orthobiologics market is expected to have positive growth and increasing demand in bone graft materials, according to a ReportsNReports analysis.
Amherst, N.Y.-based Excelsior Orthopaedics named Andrew Stoeckl, MD, president of its board of directors, according to a report by The Buffalo News.
Amherst, N.Y.-based Excelsior Orthopaedics named Andrew Stoeckl, MD, president of its board of directors, according to a report by The Buffalo News.
Ilya Laufer, MD, is a neurosurgeon providing care at Memorial Sloan Kettering's Spine Tumor Center in New York. He also serves as an assistant professor in the department of neurosurgery-spine at Memorial Sloan Kettering. He is also affiliated with New…
Depending on where you live, your treatment for spinal stenosis could be different.
A study recently published in Spine examined the morbidity, mortality and readmissions after vertebral augmentation.
Chukwuka Okafor, MD, of Spine Institute of Central Florida, was featured in The Ledger recently for his volunteer work in Florida and around the globe.
A study published in the American Journal of Sports Medicine examines the causes and risk factors for failed hip preservation surgery.
A study published in the American Journal of Sports Medicine examines the causes and risk factors for failed hip preservation surgery.